Renal Stones/Calculi Global Clinical Trials Review, H1, 2018: Ken Research
Renal stones, most commonly known as kidney stones, are
stones made of minerals and salts that are formed inside the kidneys. They are
caused by various reasons and can affect any part of the urinary tract- from
the kidney to the bladder. Passing the kidney stones can prove to be painful.
Depending on the situation, it can be cured even with pills and drinking water
to pass them on. These stones form when urine becomes concentrated and allows
the minerals to crystallize.
Clinical trials are conducted in
medical research labs to find better ways to prevent and treat diseases or
diagnose them. They give solutions to the medical approaches suitable for
certain illness to a certain group of people specifically. These trials help a
great deal in making healthcare decisions. Since they answer scientific
questions, these trials are required to be carried on under strict and
scientific standards that protect the interests of the patients. They are also
the final and the most important stage of clinical research and development.
Clinical trials for drugs take place in four phases- first, they test an
experimental drug on a few people and study the effects; second, they test the
drug on more people than in Phase 1 which may extend up to years; third, they
include many other participants to test for safety and efficacy and study the
side effects deeper than in Phase 2; fourth, getting approval of the usage of
drug from the relevant authority.
Ken Research’s Renal
Stones/Calculi Global Clinical Trials Review, H1, 2018 gives an
overview of the global clinical trials landscape and top-level data related to
clinical trials by Region, Country (G7 and E7), Trial Status, trial Phase,
Sponsor type, and Endpoint status. The report reviews top companies involved
and enlists all trials (Trial title, Phase, and Status) pertaining to the
company and all the unaccomplished trials (Terminated, Suspended and Withdrawn)
with the reason for their non-accomplishments. It provides enrolment trends for
the past five years and the latest news relating to these trials for the past
three months. The companies involved in the clinical trials of Renal Stones are
Himalaya Global Holdings Ltd, Allena Pharmaceuticals Inc, Astellas Pharma Inc,
Takeda Pharmaceutical Co Ltd, Shifa International Hospitals Ltd, Sanofi, Omeros
Corp, Dong-A Socio Group, Apis Flora Industrial e ComercialLtda, and Allergan
Plc. The report will enhance the decision- making capabilities and helps to
create an effective counter-strategy to gain a competitive advantage and helps
in identifying locations for conducting these trials.
To know more,
click on the link below:
Related
reports:
Contact us:
Ken
research
Ankur Gupta,
head marketing & communications
+91-9015378249
Comments
Post a Comment